Cendekia Journal of Pharmacy
Vol 8, No 2 (2024): Cendekia Journal of Pharmacy

EVALUASI PENGGUNAAN OBAT ANTIDIABETIKA PADA PROGRAM RUJUK BALIK DI APOTEK X KABUPATEN JAYAPURA

Pitasari, Nawang Wulan Nago (Unknown)
Risna, Risna (Unknown)



Article Info

Publish Date
30 May 2024

Abstract

The availability of Refer-Back Program (DRR) drugs is one of the factors in the success of DRR services in health facilities. The purpose of this study was to determine the quantity of use of antidiabetic drugs with the ATC / DDD and DU methods of 90% and the percentage of conformity of antidiabetic drugs with the National Formulary (Fornas). The method used is a type of cross-sectional observational research with a descriptive approach. Retrospective data collection for the period January-December 2022 at Apotek X BPJS Kesehatan Network in the Jayapura regency area. The results of this study showed that the most use of antidiabetic drugs was metformin (5,715.8 DDD / 1,000 / year). Antidiabetics included in the 90% DU segment are metformin, novorapid®, gliquidone and glimepiride and the level of prescribing compliance with Fornas reaches 100%.

Copyrights © 2024






Journal Info

Abbrev

cjp

Publisher

Subject

Medicine & Pharmacology

Description

Cendekia Journal of Pharmacy published by the Program Studi Farmasi STIKES Cendekia Utama Kudus with registered number ISSN 2599-2163 (Print) and for ISSN (Online) is 2599-2155. This journal is published twice a year, in November and May. ...